Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...

With colon cancer rates rising throughout the world, particularly in adults under 50, finding a way to lessen the chance of ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

Learn how colon cancer patients can reap the benefits of exercise, potentially raising the chances of survival post-surgery ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

With the benefits rivaling some drugs, experts said cancer centers and insurance plans should consider making exercise ...

A single-center study supported recommendations to lower the colorectal cancer screening age from 50 to 45. A single-center ...

Losing weight is often seen as a fast track to better health—but there’s a line between healthy habits and harmful extremes.

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Post-chemotherapy exercise significantly boosts disease-free survival in colon cancer patients, underscoring the importance ...

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, ...

New evidence has linked physical activity with improved colon health, underscoring the vital role of exercise in cancer ...